Mission Creek Capital Partners Inc. Buys 855 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Mission Creek Capital Partners Inc. increased its stake in DocuSign, Inc. (NASDAQ:DOCU) by 4.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 21,934 shares of the company’s stock after purchasing an additional 855 shares during the quarter. Mission Creek Capital Partners Inc.’s holdings in DocuSign were worth $1,362,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Massmutual Trust Co. FSB ADV lifted its stake in DocuSign by 5,000.0% in the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $27,000 after acquiring an additional 500 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in DocuSign in the 3rd quarter valued at about $28,000. Mather Group LLC. grew its holdings in DocuSign by 4,338.5% during the second quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after purchasing an additional 564 shares during the period. Brooklyn Investment Group bought a new position in DocuSign during the third quarter worth about $33,000. Finally, Reston Wealth Management LLC acquired a new position in DocuSign during the third quarter worth approximately $47,000. 77.64% of the stock is owned by institutional investors.

DocuSign Trading Up 0.2 %

Shares of DOCU opened at $80.45 on Wednesday. DocuSign, Inc. has a 12 month low of $44.34 and a 12 month high of $86.75. The firm’s 50 day moving average is $72.86 and its 200-day moving average is $61.36. The stock has a market capitalization of $16.33 billion, a PE ratio of 16.97, a P/E/G ratio of 8.31 and a beta of 0.92.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.17. The business had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.09 earnings per share. Equities research analysts predict that DocuSign, Inc. will post 1.03 earnings per share for the current fiscal year.

Insider Buying and Selling

In other DocuSign news, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the sale, the director now directly owns 7,202 shares in the company, valued at $407,345.12. This represents a 6.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the transaction, the chief executive officer now owns 100,062 shares of the company’s stock, valued at $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 69,596 shares of company stock worth $4,441,529. Company insiders own 1.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on DOCU shares. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, September 6th. Jefferies Financial Group lifted their price objective on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Tuesday. Robert W. Baird increased their price objective on shares of DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Citigroup raised their target price on shares of DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday, September 6th. Finally, Bank of America upped their price target on shares of DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and a consensus target price of $70.73.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.